64.11  2.99 (4.89%)		07-28 16:00
Open: 61.4 High: 64.2525 Volume: 7,966,202		Pre. Close: 61.12 Low: 61.4 Market Cap: 29,163(M)

Short term
Mid term
Targets	6-month :	77.56	1-year :	90.6
Resists	First :	66.41	Second :	77.56
Pivot price	63.11
Supports	First :	62.57	Second :	60.2
MAs	MA(5) :	61.82	MA(20) :	63.53
	MA(100) :	66.41	MA(250) :	73.24
MACD	MACD :	-0.6	Signal :	-0.5
%K %D	K(14,3) :	28.5	D(3) :	19.6
RSI	RSI(14): 52.7
52-week	High :	89.64	Low :	58.71

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GEHC ] has closed below upper band by 34.2%. Bollinger Bands are 25.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	64.34 - 64.6	64.6 - 64.84
Low:	60.77 - 61.05	61.05 - 61.32
Close:	63.65 - 64.1	64.1 - 64.53

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Tue, 28 Jul 2026
A Look at GE HealthCare Technologies Inc (GEHC) After 4.9% Gain -- GF Value $85.42 vs Price $64.11 - GuruFocus

Tue, 28 Jul 2026
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q2 Earnings - Yahoo Finance

Mon, 27 Jul 2026
GE HealthCare (GEHC) To Report Earnings Tomorrow: Here Is What To Expect - TradingView

Mon, 27 Jul 2026
GEHC|GE Healthcare Technologies Inc|Price:62.530|Chg%:+1.410 - TradingKey

Sun, 26 Jul 2026
GE HealthCare Technologies Inc. (GEHC) Beats Q2 Expectations, Reaffirms 2026 Outlook Despite CFO Transition - Yahoo Finance UK

Sat, 25 Jul 2026
Ge Healthcare Technologies Inc. (GEHC) Q1 2023 Earnings Report - Results, Call & Slides - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	455 (M)
Shares Float	453 (M)
Held by Insiders	0.3 (%)
Held by Institutions	94.9 (%)
Shares Short	18,450 (K)
Shares Short P.Month	15,580 (K)

EPS	4.17
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	23.45
Profit Margin	9.1 %
Operating Margin	11 %
Return on Assets (ttm)	5.1 %
Return on Equity (ttm)	19.4 %
Qtrly Rev. Growth	7.4 %
Gross Profit (p.s.)	18.04
Sales Per Share	46.12
EBITDA (p.s.)	7.73
Qtrly Earnings Growth	-30.9 %
Operating Cash Flow	2,030 (M)
Levered Free Cash Flow	1,480 (M)

PE Ratio	15.37
PEG Ratio	1.7
Price to Book value	2.73
Price to Sales	1.39
Price to Cash Flow	14.36

Dividend	0.03
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.